Pfizer’s Competitive Grants Program (various)

Organization
Pfizer
Type
Industry
Comments
Filter list by selecting Oncology for Focus Area
Brief Description

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Note that the following oncology grants are available:

Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer
View RFP (PDF)
Application Due Date: October 29, 2020

Remote Mentoring Programs in RCC
View RFP (PDF)
Application Due Date: October 15, 2020

PARP-inhibitor Combination Treatments in Prostate Cancer
View RFP (PDF)
Application Due Date: October 14, 2020

Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
View RFP (PDF)
Application Due Date: November 2, 2020

NSCLC Oncogene Driver Considerations in Testing & Treatment
View RFP (PDF)
Application Due Date: October 29, 2020

Biosimilars in Hematologic Malignancies & Supportive Care
View RFP (PDF)
Application Due Date: November 2, 2020